AzTrials
AzTrials

Language DevelopmentNCT03366831

Newborn Implementation

A study testing Thirty Million Words Initiative Newborn Intervention in people with Language Development, run by University of Chicago at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the proposed research is to perform testing of the Thirty Million Words Newborn Initiative (TMW-NI) with the primary goal of evaluating various implementation methods. The investigators hypothesize that the TMW-Newborn intervention will: 1. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Language Development
What is being tested?
Thirty Million Words Initiative Newborn Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,701 participants
Where
3 sitesUnited States
Study dates
10 Apr 2017to 6 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • New mothers at Sacred Heart Hospital, University of Chicago Medical Center, and Baptist Hospital-Pensacola.

Who cannot join

  • Individuals that do not have a live birth at Sacred Heart Hospital, University of Chicago Medical Center, or Baptist Hospital-Pensacola or do not receive the UNHS at one of these locations will not be eligible for this study.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • TMW Center for Early Learning + Public Health at the University of Chicago Medicine

    Chicago, Illinois, 60637

  • Sacred Heart Hospital

    Pensacola, Florida, 19141

  • Baptist Hospital

    Pensacola, Florida, 32501

Other trials in United States

About this study

Official title: Thirty Million Words Initiative Newborn Implementation Trial

The purpose of the proposed research is to perform testing of the Thirty Million Words Newborn Initiative (TMW-NI) with the primary goal of evaluating various implementation methods.

The investigators hypothesize that the TMW-Newborn intervention will:

Read more
  1. Significantly impact parent knowledge regarding the importance of universal newborn hearing screen (UNHS) follow-up
  2. Significantly impact parent knowledge of child development Additionally,the investigators hypothesize that:
  3. The 7-minute version of the video with questions interspersed will most significantly improve parent knowledge of child development
  4. There will be no significant differences in effectiveness of the Spanish and English versions of the TMW-Newborn intervention

The hypotheses rely on the existing research data supporting the idea that parental understanding and beliefs will alter parental behavior, and consequently, that increased parental linguistic input will impact child cognitive development.

Read the detailed description

The investigators propose to perform a randomized implementation trial to evaluate the efficacy of various implementation methods of the TMW-Newborn educational intervention. The study will be conducted in temporal proximity to the administration of the universal newborn hearing screen.

After routine delivery, postpartum mothers are admitted to the mother-baby unit for 48-72 hours. A hearing screening technician of the Sacred Heart Hospital will deliver the tablet that houses the intervention to every mother whose child is receiving the hearing screening. The technician will give each mother a tablet set up to the HIPAA Compliant TMW-Newborn Web Platform that houses the randomization tool, the welcome video, the tablet based consent passage, the surveys, and the educational intervention videos. First, the participant will watch the welcome video and complete the tablet based consent. Then, the participant will be randomized into one of four conditions: 15 minute version of the TMW-Newborn intervention video without questions interspersed, the 15 minute version of the TMW-Newborn intervention video with questions interspersed, the 7 minute version of the TMW-Newborn intervention video without questions interspersed, or the 7 minute version of the TMW-Newborn intervention video with questions interspersed.

After randomization, the participant will be brought to the screen with the SPEAK III to complete. Then, they will answer a few non-identifying demographics questions. These surveys takes approximately 10 minutes to complete will be followed by either a 15-minute or 7-minute video.

After watching their assigned video, all participants will repeat the SPEAK questionnaire for a second time. Then, the hearing screener will pick up the tablet from the participant. No identifying information is being collected within the TMW-Newborn web platform, and the hearing screening technicians will not be able to see or access any of the participants' responses.

After all surveys are complete, the hearing screening technician will pick up the tablet from the participant and answer any remaining questions.

This study protocol will only be used at Sacred Heart Hospital, Baptist Hospital, and University of Chicago Hospital.

Being tested
Thirty Million Words Initiative Newborn Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thirty Million Words Initiative Newborn InterventionBehavioural

    The Thirty Million Words Initiative Newborn Intervention (TMW-Newborn) is a public health effort aimed at increasing awareness about the importance of a child's early language environment in his or her first years of life. This one-time educational intervention will be impacting maternal awareness and knowledge about the importance of children's early language environment, between ages 0 and 3.

Study groups in NCT03366831
Study groupRoleWhat they receive
15 minute version without questionsActive comparator15 minute version of the TMW-Newborn intervention video without questions interspersed
Receives: Behavioral: Thirty Million Words Initiative Newborn Intervention
15 minute version with questionsActive comparator15 minute version of the TMW-Newborn intervention video with questions interspersed
Receives: Behavioral: Thirty Million Words Initiative Newborn Intervention
7 minute version without questionsActive comparator7 minute version of the TMW-Newborn intervention video without questions interspersed
Receives: Behavioral: Thirty Million Words Initiative Newborn Intervention
7 minute version with questionsActive comparator7 minute version of the TMW-Newborn intervention video with questions interspersed.
Receives: Behavioral: Thirty Million Words Initiative Newborn Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SPEAK Survey (Baby Subscales)

    measures an individuals expectations and knowledge about child development

    Measured: 48-72 after routine delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2017
  2. Study start10 Apr 2017
  3. Primary completion6 Nov 2019
  4. Study completion6 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
2,701 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03366831
Sponsor's protocol ID
17-0329
Status last verified
May 2023
First submitted
4 Dec 2017
Last updated
10 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared

Publications

  • Suskind DL, Leung CYY, Webber RJ, Hundertmark AC, Leffel KR, Fuenmayor Rivas IE, Grobman WA. Educating Parents About Infant Language Development: A Randomized Controlled Trial. Clin Pediatr (Phila). 2018 Jul;57(8):945-953. doi: 10.1177/0009922817737079. Epub 2017 Oct 26.

    PubMed 29073768

Questions about this trial

What is this clinical trial studying?

A study testing Thirty Million Words Initiative Newborn Intervention in people with Language Development, run by University of Chicago at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SPEAK Survey (Baby Subscales) (time frame: 48-72 after routine delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03366831, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in